Litcius/Paper detail

Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity

Andrew W. Daman, Anthony C. Antonelli, Gil Redelman‐Sidi, Lucinda Paddock, Shireen Khayat, Mythili Ketavarapu, Jin‐Gyu Cheong, Leonardo F. Jurado, Anna Benjamin, Song Jiang, Dughan Ahimovic, Victoria R. Lawless, Michael J. Bale, Oleg Loutochin, Victor McPherson, Maziar Divangahi, Rachel Niec, Dana Pe’er, Eugene J. Pietzak, Steven Z. Josefowicz, Michael S. Glickman

2025Cancer Cell36 citationsDOIOpen Access PDF

Topics & Concepts

HaematopoiesisImmunotherapyMyeloid cellsImmunityCancerMyeloidCancer researchBiologyCancer immunotherapyImmunologyImmune systemStem cellCell biologyGeneticsImmune responses and vaccinationsImmune cells in cancerImmunotherapy and Immune Responses
Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity | Litcius